Association of Symptoms and Cytokines in Prostate Cancer Patients Receiving Radiation Treatment

Abstract

Introduction:

Men with prostate cancer undergoing radiation treatment frequently report fatigue, insomnia, depression, anxiety and urinary, bowel, sexual, and hormonal symptoms. Plasma concentrations of cytokines may be related to these symptoms, but few studies have examined these relationships. The study purpose was to explore the association between prostate cancer symptoms and cytokine levels at pretreatment and posttreatment.

Method:

In this longitudinal, correlational study, 29 men with nonmetastatic prostate cancer completed symptom questionnaires at preradiation and postradiation treatment. Blood drawn at these same time points was used to determine levels of tumor necrosis factor-alpha (TNF-α) and interleukins-1β, 6, 10, and 4 (IL-1β, IL-6, IL-10, and IL-4).

Results:

Men reported symptom severity at pretreatment and posttreatment as low to moderate. There were significant differences from pretreatment to posttreatment in fatigue, insomnia, urinary irritative and incontinence, bowel, sexual, and hormonal problems. There were no significant differences in TNF-α, IL-6, IL-10, or IL-4. At pretreatment, TNF-α was associated with depression, anxiety, urinary irritative, and bowel problems, and IL-4 was related to urinary irritative symptoms. At posttreatment, IL-4 was associated with urinary irritative symptoms. Findings suggest that, in men with prostate cancer, there is no strong association between symptom reporting and cytokine levels. Ongoing research focused on neuroendocrine and genetic markers and their associations with symptoms is promising and may result in the provision of better markers for quantifying the symptom experience in patients with cancer.

Keywords

cancer prostate symptoms cytokines

Get full access to this article

View all access options for this article.

References

Ahlberg

Ekman

Gaston-Johansson

(2004). Levels of fatigue compared to levels of cytokines and hemoglobin during pelvic radiotherapy: A pilot study. Biological Research for Nursing, 5, 203–210.

American Cancer Society. (2013). Cancer facts and figures 2013. Atlanta, GA: Author.

Arend

(2002). The balance between IL-1 and IL-1ra in disease. Cytokine & Growth Factor Reviews, 13, 323–340.

Aubert

Vega

Dantzer

Goodall

(1995). Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain, Behavior, and Immunity, 9, 129–148.

Bastien

C. H.

Vallieres

Morin

C. M.

(2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2, 297–307.

Bjelland

Dahl

A. A.

Haug

T. T.

Neckelmann

(2002). The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research, 52, 69–77.

Bower

Ganz

Tao

Belin

Sepah

… Aziz

(2009). Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clinical Cancer Research, 15, 5534–5540.

Bower

J. E.

Ganz

P. A.

Aziz

Olmstead

Irwin

M. R.

Cole

S. W.

(2007). Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids. Brain, Behavior, and Immunity, 21, 251–258.

Brandeis

J. M.

Litwin

M. S.

Burnison

C. M.

Reiter

R. E.

(2000). Quality of life outcomes after brachytherapy for early stage prostate cancer. Journal of Urology, 163, 851–857.

10.

Burgos

Richter

Klein

Fiebich

Feige

Lieb

… Riemann

(2006). Increased nocturnal interleukin-6 excretion in patients with primary insomnia: A pilot study. Brain, Behavior, and Immunity, 20, 246–253.

11.

Cleeland

C. S.

Bennett

G. J.

Dantzer

Dougherty

P. M.

Dunn

A. J.

Meyers

C. A.

… Lee

B. N.

(2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97, 2919–2925.

12.

Cohen

(1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum.

13.

Dantzer

Capuron

Irwin

M. R.

Miller

A. H.

Ollat

Perry

V. H.

… Yirmiya

, (2008). Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology, 33, 18–29.

14.

Dirksen

Epstein

Hoyt

(2009). Insomnia, depression and distress among outpatients with prostate cancer. Applied Nursing Research, 22, 154–158.

15.

Fitch

M. I.

Gray

Franssen

Johnson

(2000). Men’s perspectives on the impact of prostate cancer. Implications for oncology nurses. Oncology Nursing Forum, 27, 1255–1263.

16.

Geinitz

Zimmermann

Stoll

Thamm

Kaffenberger

Ansorg

… Molls

(2001). Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. International Journal of Radiation Oncology*Biology*Physics, 51, 691–698.

17.

Geinitz

Zimmermann

F. B.

Thamm

Keller

Busch

Molls

(2004). Fatigue in patients with adjuvant radiation therapy for breast cancer: Long-term follow-up. Journal of Cancer Research and Clinical Oncology, 130, 327–333.

18.

Greenberg

D. B.

Gray

J. L.

Mannix

C. M.

Eisenthal

Carey

(1993). Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. Journal of Pain and Symptom Management, 8, 196–200.

19.

Hervouet

Savard

Simard

Ivers

Laverdière

Vigneault

… Lacombe

(2005). Psychological functioning associated with prostate cancer: Cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. Journal of Pain and Symptom Management, 30, 474–484.

20.

Jehn

Kuehnhardt

Bartholomae

Jehn

Kuehnhardt

Pfeiffer

… Flath

B. C.

(2006). Biomarkers of depression in cancer patients. Cancer, 107, 2723–2729.

21.

Khan

S. S.

Smith

M. S.

Reda

Suffredini

A. F.

McCoy

J. P.

(2004). Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry Part B: Clinical Cytometry, 61B, 35–39.

22.

Kovacs

Daly

Evans

Johnke

Lee

Karlsson

… Biggs

(2003). Cytokine profiles in patients receiving wide-field and prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate. Cytokine, 23, 151–163.

23.

Lee

S. O.

Chun

Nadiminty

Lou

Feng

Gao

A. C.

(2009). IL-4 activates androgen receptor through CBP/p300. Prostate, 1, 126–132.

24.

Hodgson

Watson

Shukla

Nelson

(2012). Comorbidities and concomitant medication use in men with prostate cancer or high levels of PSA compared to matched controls: A GPRD analysis. Journal of Cancer Epidemiology, 2012, 1–32.

25.

Lopes

Callera

(2012). Three-dimensional conformal radiotherapy in prostate cancer patients: Rise in interleukin 6 (IL-6) but not in IL-2, IL-4, IL-5, tumor necrosis factor-α, MIP-1-α and LIF levels (2011). International Journal of Radiation Oncology*Biology*Physics, 82, 1385–1388.

26.

Lyon

Walter

Munro

Schubert

McCain

(2011). Challenges in interpreting cytokine biomarkers in biobehavioral research: A breast cancer exemplar. Biological Research for Nursing, 13, 25–31.

27.

Maes

(1995). Evidence for an immune response in major depression: A review and hypothesis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 19, 11–38.

28.

McNair

Lorr

Droppleman

(1971). Manual for the profile of mood states. San Diego, CA: Educational and Industrial Testing Service.

29.

Miaskowski

Aouizerat

(2012). Biomarkers: Symptoms, survivorship, and quality of life. Seminars in Oncology Nursing, 28, 129–138.

30.

Monga

Kerrigan

A. J.

Thornby

Monga

(1999). Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiation Oncology Investigations, 7, 178–185.

31.

Moorey

Greer

Watson

Gorman

Rowden

Tunmore

… Bliss

(1991). The factor structure and factor stability of the Hospital anxiety and depression scale in patients with cancer. British Journal of Psychiatry, 158, 255–259.

32.

Morin

C. M.

(1993). Insomnia: Psychological assessment and management. New York, NY: Guilford Press.

33.

Musselman

Miller

Porter

Manatunga

Gao

Penna

… Nemeroff

(2001). Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. American Journal of Psychiatry, 158, 1252–1257.

34.

Opal

S. M.

DePalo

V. A.

(2000). Anti-inflammatory cytokines. Chest, 117, 1162–1172.

35.

Quatan

Meyer

Bailey

Pandha

(2006). Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomy. Prostate Cancer and Prostatic Diseases, 9, 420–425.

36.

Richins

J. L.

Urbanowicz

R. A.

Metcalf

Corne

O’Shea

Fairclough

(2010). Quantitative validation and comparison of multiplex cytokine kits. Journal of Biomolecular Screening, 15, 562–568.

37.

Satariano

W. A.

Ragheb

N. E.

Dupuis

M. H.

(1989). Comorbidity in older women with breast cancer: An epidemiologic approach. In Yancik

Yates

(Eds.), Cancer in the elderly: Approaches to early detection and treatment (pp. 71–107). New York, NY: Springer.

38.

Schubert

Hong

Natarajan

Mills

P. J.

Dimsdale

J. E.

(2007). The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain, Behavior, and Immunity, 21, 413–427.

39.

Sothern

R. B.

Roitman-Johnson

Kanabrocki

E. L.

Yager

J. G.

Fuerstenberg

R. K.

Weatherbee

J. A.

… Schering

L. E.

(1995). Circadian characteristics of interleukin-6 in blood and urine of clinically healthy men. In Vivo, 9, 331–339.

40.

Soygur

Palaoglu

Akarsu

E. S.

Cankurtaran

E. S.

Ozalp

Turhan

Ayhan

I. H.

(2007). Interleukin-6 and HPA axis activation in breast cancer patients with major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 1242–12477.

41.

Steptoe

Hamer

Chida

(2007). The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain, Behavior, and Immunity, 21, 901–912.

42.

Talluri

Marella

Shirazian

Wise

(2000). Immune response in patients with hormone treated prostate cancer. Journal of the American College of Surgeons, 191, S94.

43.

van Andel

Kurth

K. H.

(2003). The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer. European Urology, 44, 209–214.

44.

Vgontzas

A. N.

Zoumakis

Papanicolaou

D. A.

Bixler

E. O

Prolo

Lin

H. -M.

… Chrousos

G. P.

(2002). Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism, 51, 887–892.

45.

Wei

J. T.

Dunn

R. L.

Litwin

M. S.

Sandler

H. M.

Sanda

M. G.

(2000). Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology, 56, 899–905.

46.

Wei

J. T.

Dunn

R. L.

Sandler

H. M.

McLaughlin

P. W.

Montie

J. E.

Litwin

M. S.

… Sanda

M. G.

(2002). Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. Journal of Clinical Oncology, 20, 557–566.

47.

Wise

Marella

Talluri

Shirazian

(2000). Cytokine variations in patients with hormone treated prostate cancer. Journal of Urology, 164, 722–725.

48.

Yeh

H. C.

Liu

C. C.

Lee

Y. C.

W. J.

W. M.

C. C.

… Huang

S. P.

(2012). Associations of the lower urinary tract symptoms with the lifestyle, prostate volume, and metabolic syndrome in the elderly males. Aging Male, 15, 166–172.

49.

Young

M. R.

Matthews

J. P.

Kanabrocki

E. L.

Sothern

R. B.

Roitman-Johnson

Scheving

L. E.

(1995). Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor in men. Chronobiology International, 12, 19–27.

50.

Zhou

Fragala

M. S.

McElhaney

J. E.

Kuchel

G. A.

(2010). Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Current Opinion in Clinical Nutrition & Metabolic Care, 13, 541–547.

51.

Zigmond

A. S.

Snaith

R. P.

(1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361–370.